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Abstract
Background: Prompt laboratory diagnosis of Herpes simplex virus (HSV) infection facilitates
patient management and possible initiation of antiviral therapy. In our laboratory, which receives
various specimen types for detection of HSV, we use enzyme immunoassay (EIA) for rapid
detection and culture of this virus. The culture of HSV has traditionally been accepted as the
diagnostic 'gold standard'. In this study, we compared the use of real time PCR (LightCycler) for
amplification, detection and subtyping of specific DNA with our in-house developed rapid and
culture tests for HSV.
Results: The LightCycler PCR (LC-PCR) detected and subtyped HSV in 99% (66/67) of HSV
positive specimens, compared to 81% (54/67) by rapid antigen EIA or 57% (36/63) by culture. A
specimen was considered positive when two or more tests yielded HSV identifications or was
culture positive. Discordant results were confirmed with an in-house developed PCR-ELISA or
DNA sequence analysis. The typing results obtained with the LC-PCR and by culture amplified test
were completely concordant.
Conclusions:  This study showed that the LC-PCR provided a highly sensitive test for
simultaneous detection and subtyping of HSV in a single reaction tube. In addition to increased
sensitivity, the LightCycler PCR provided reduced turn-around-times (2 hours) when compared to
enzyme immunoassay (4 hours) or culture (4 days).
Background
Herpes simplex virus (HSV) infection in adults is usually
benign (e.g. oral cold sores) [18]. When it occurs in critical
anatomical sites, for example ocular or central nervous
system, or acquired by the neonate during parturition, the
sequelae may lead to serious complications [16,17]. There
are two subtypes of herpes simplex virus – HSV 1 and HSV
2, both of which a patient may be concurrently infected
with [15]. One central feature of HSV infection is reactiva-
tion from the sensory nervous system of latently infected
humans, although the triggers for this are not well de-
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fined. Infection with HSV is thus lifelong with unpredict-
able reactivations in which lesions may not always be
manifested [9].
Laboratory diagnosis of HSV infection has relied on virus
isolation in cell cultures and rapid tests viz. enzyme im-
munoassays (EIA) [7], immunofluorescence [4] or nucleic
acid amplification by PCR [10]. In our laboratory, which
provides a diagnostic service for hospital inpatients and
outpatients as well as private physicians, genital, ocular
and cutaneous specimens are regularly submitted for rou-
tine HSV detection. These are tested by rapid EIA and in-
oculated into cell culture with subsequent detection and
subtyping of viral isolates by specific monoclonal anti-
bodies.
Recently the availability of real time quantitative PCR
with the LightCycler (Roche Diagnostics) has enabled a
significant improvement in rapid detection (<1 hr) of
HSV nucleic acid sequences compared to conventional
PCR and gel electrophoresis [2,3]. The LightCycler enables
rapid PCR amplification of target nucleic acid due to the
high temperature transition rates (20°C/sec) facilitated by
specially designed glass capillary reaction vessels and tem-
perature control via heated or ambient air. Real-time
monitoring of amplified DNA product formation and
characterisation is also possible using a pair of fluores-
cence-labelled hybridisation probes. Hybridisation of the
probes in close proximity (< 5 nucleotides separation) re-
sults in fluorescence resonance energy transfer (FRET) be-
tween the flourophores. The donor fluorophore
(fluorescein) is excited by light emitted from the LightCy-
cler instrument and part of the excitation energy it releases
is transferred to the accepter flourophore (LC-Red 640 or
LC-Red 705). The resulting energy emitted by the acceptor
fluorophore is measured by the LightCycler and is propor-
tional to the amount of specific PCR product in the reac-
tion mix.
Using primers and hybridisation probes designed to ena-
ble optimal separation of viral DNA subtype melting
curves, we compared detection and subtyping of HSV by
rapid EIA and culture with the LightCycler PCR.
Results
Calibration of LightCycler PCR
Figure 1 shows typical LightCycler amplification curves
with HSV DNA extracted from three specimens and two
concentrations of HSV-1 and HSV-2 positive controls with
Figure 1BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/12
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the corresponding melting curves differentiating HSV-1
and HSV-2 subtypes (Fig. 2).
Sensitivity
Limiting dilutions of HSV-1 and HSV-2 stock cultures
were prepared in 105 A549 epithelial cells (or in viral
transport medium, VTM) followed by DNA extraction and
subsequently tested in the LightCycler. There was no dif-
ference in detection sensitivity of HSV-1 or 2 whether di-
luted in A549 cells or in VTM. The endpoint dilution
obtained with the LC-PCR was 10-0.5/ml for HSV-1 and
10-1.2/ml for HSV-2. The corresponding endpoint dilu-
tions obtained with HSV PCR-ELISA were 101.6/ml for
HSV-1 and 100.2/ml for HSV-2.
The limit of detection for both HSV-1 and 2 using HSV
plasmid DNA was calculated to be 20 copies/reaction
(equivalent to 4 copies/µl). This is similar to the detection
sensitivity of 20 copies of HSV DNA [3] and ≥ 10 copies of
Parvovirus B19 DNA per reaction (Roche Molecular Diag-
nostics). The HSV-1 and 2 plasmid DNA sequences
aligned perfectly with the corresponding sequences of
HSV-1 and 2 obtained from GenBank.
Specificity
The specificity of the LC-PCR was confirmed by testing
DNA extracted from Varicella zoster virus (clinical iso-
late), cytomegalovirus (AD 169 strain), cytomegalovirus
(clinical isolate) and B95a (Epstein-Barr virus – trans-
formed lymphoblastoid line) [6]. No amplified DNA was
detected from any of these samples.
Absence of cross-contamination during DNA extractions
When double blind coded samples were prepared and
tested under standard operating procedures for nucleic
acid extractions and amplifications in our laboratory, the
results obtained were concordant with the sample codes
viz. the appropriate samples were identified as two posi-
tive for HSV-1 and three HSV-2, with the remaining 19
samples negative for HSV DNA in the LC-PCR. These con-
cordant results suggest the absence of cross-contamina-
tion during DNA extractions.
Detection of Herpes simplex virus by LightCycler PCR, en-
zyme immunoassay and cell culture
There were 75 (29%) specimens positive for HSV by LC-
PCR (50 were HSV-1 and 25 HSV-2), 55 (21%) were pos-
itive by rapid antigen EIA and 36 (14%) positive by cul-
ture amplified test (26 were HSV-1, 8 were HSV-2 and 2
were untypeable). A culture result was not obtained in 21
Figure 2BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/12
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specimens due to bacterial/fungal contamination. There
were insufficient materials from the latter specimens for
filtration and repeat culture. If these specimens are exclud-
ed, the detection rate by culture amplified test is 15% (36/
241). Specimens which were LC-PCR positive but nega-
tive by rapid antigen EIA and culture were tested by PCR-
ELISA.
Comparison of LightCycler PCR with rapid antigen EIA 
and culture amplification
Table 1 compares the LC-PCR with rapid antigen EIA for
detection of HSV. Of the 55 specimens which were posi-
tive in the rapid antigen EIA 53 were LC-PCR positive. Of
the two specimens negative by LC-PCR (but rapid antigen
EIA positive) one was culture positive and the remaining
specimen yielded bacterial contamination in the culture
amplified test. There were 22 (75–53) specimens which
were LC-PCR positive but negative by rapid antigen. Of
these 22 (12 HSV-1 & 10 HSV-2) specimens, 12 were pos-
itive by PCR-ELISA and an additional one was culture pos-
itive. There were 7 specimens which were LC-PCR positive
only. Analysis of the LC-PCR amplified DNA sequences
from the latter specimens confirmed that HSV DNA had
been amplified, although this may not be regarded as an
independent detection test.
There were 36 specimens positive in the culture amplified
test (Table 1). All but one of these specimens were also
positive in the LC-PCR test. The specimen which was neg-
ative by LC-PCR but culture amplified positive was also
positive in the rapid antigen EIA.
Overall there were 67 specimens positive by two or more
tests viz. LC-PCR, rapid antigen EIA, PCR-ELISA or culture
(see Table 1). If a true positive is defined as a specimen
positive in at least two tests or culture positive, then the
sensitivity, specificity, positive predictive value and nega-
tive predictive value for LC-PCR are 99% (66/67), 95%
(171/180), 88% (66/75) and 99% (171/172), for rapid
antigen EIA are 81% (54/67), 100% (178/178), 100%
(54/54), 93% (178/191) and for culture are 57% (36/63),
100% (178/178), 100% (36/36), 87% (178/205). Speci-
mens which yielded contamination in the culture ampli-
fied test were excluded in this analysis, except those which
were positive by two or more tests.
The difference in sensitivities between the LC-PCR and
rapid antigen EIA (χ 2 12.12, degrees of freedom 1 and p =
0.0005), LC-PCR and culture (χ 2 39.54, degrees of free-
dom 1 and p < 0.0001) or rapid antigen EIA and culture
(χ 2 15.27, degrees of freedom 1 and p < 0.0001) were sta-
tistically significant. Multinomial logistic regression was
used to compare the sensitivities between the tests. The
comparison of sensitivities was calculated using the
weighted least squares method of Grizzle et al. [5].
HSV subtyping by LC-PCR and culture amplified test
All specimens positive in the LC-PCR were subtyped by
melting curve analysis with 50 identified as HSV-1 and 25
as HSV-2 (Table 1). There were 36 culture positive speci-
mens subtyped, with 26 HSV-1, 8 HSV-2 and 2 untypeable
(see Table 1). The latter two specimens yielded equivocal
subtype results even though the isolates were identified as
HSV in the rapid antigen EIA. However, there was com-
plete concordance between LC-PCR and culture amplified
test with subtype identifications. The two specimens
which yielded inconclusive typing results in the culture
amplified test were both identified as HSV-1 by LC-PCR
while the one culture positive but LC-PCR negative speci-
men was HSV-2.
Discussion
The availability of antiviral therapy [13,18] and the re-
quirement for patient management has increased demand
for rapid laboratory diagnosis of HSV infection. Detection
of virus by enzyme immunoassay or immunofluorescence
staining of infected cells have offered rapid diagnosis,
with virus isolation in cell cultures used as the reference
test ("gold standard") or subtyping of HSV [7]. Detection
of HSV DNA by PCR has primarily been used to test cere-
brospinal fluid (CSF) samples in patients with suspected
herpes encephalitis where the low levels of HSV in CSF
samples required the use of the most sensitive test possi-
ble [10].
The use of real time amplification and detection of nucleic
acids in sealed capillary tubes in the LC-PCR has signifi-
Table 1: Comparison of LightCycler PCR (LC-PCR) with rapid an-
tigen EIA and culture amplified detection of Herpes simplex virus 
in 262 specimens.
Number 
(Total = 262)
Light-Cycler Rapid anti-
gen EIA
Culture 
Amplified
34 + + +
4α ++ c o n t a m i n a t e d
15 + + -
19β +--
2γ +- c o n t a m i n a t e d
1+ - +
Subtotal = 75
1δ -+ c o n t a m i n a t e d
1- + +
185φ ---
Subtotal = 187
Notesα  4/4 culture contaminated. β  12/19 PCR-ELISA positive and 7/
19 negative. γ  2/2 PCR-ELISA negative and culture contaminated. δ  1/1 
PCR-ELISA negative and culture contaminated. φ 14/185 culture con-
taminated.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/12
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cantly increased test efficiency in three ways. Firstly, am-
plification and detection of HSV DNA, followed by
subtyping, can be completed within one hour post extrac-
tion of nucleic acids from specimens compared to >6 hrs
with conventional PCR amplification followed by ampli-
con detection in gel electrophoresis or ELISA [8]. Second-
ly, the use of two closely-spaced (separated by 2
nucleotides) fluorescence-labelled hybridisation probes
(28 and 21 mers) adds to specificity confirmation of am-
plified sequences. Thirdly, being a sealed system the at-
tendant potential problem of contamination with
amplified nucleic acid sequences is minimized.
In this study, the sensitivity of LC-PCR (99%) exceeded
that of rapid antigen EIA (81%) and culture (57%) in
which a true positive specimen was defined as having two
or more positive test identifications. The LC-PCR specifi-
city and positive predictive value would be higher (100%
in both determinations) if the nine LC-PCR positive spec-
imens that were negative by other tests were considered as
true positives. We believe that it is likely that these nine
LC-PCR results are true positive for the following reasons.
DNA sequence analysis of the LC-PCR products con-
firmed their identities as being concordant with HSV DNA
sequences obtained from GenBank (data not shown),
thus excluding false positives due to other agents. The lab-
oratory practice of strict separation of preparation, set-up
and analysis areas for PCR procedures as well as the con-
cordant results obtained with the double blind coded
samples support the argument that it is unlikely that there
was contaminating HSV DNA. It may be expected that
these nine LC-PCR positive specimens would be positive
in the PCR-ELISA. The latter amplified a different region
(from the LC-PCR) of the HSV DNA polymerase gene. The
PCR-ELISA was shown to have a detection sensitivity of 24
copies/µl compared to 4 copies/µl with LC-PCR. Finally
specimens which were HSV DNA positive but virus culture
negative have also been reported by others [1,3]. If these
nine LC-PCR specimens were considered true positives,
then the revised sensitivity, specificity, positive predictive
and negative predictive values for the LC-PCR are 99%
(73/74), 100% (171/171), 100% (73/73) and 99% (171/
172).
Conclusions
The typing results obtained with the LC-PCR and by cul-
ture amplified test were completely concordant. The LC-
PCR provides a highly sensitive and rapid test for detec-
tion of HSV with immediate differentiation between types
1 and 2 in a single reaction tube. Since these results can be
achieved at reduced costs and in a shorter period when
compared to antigen detection or culture, the LC-PCR or
similar real time nucleic acid amplification tests are likely
to become the test of choice for diagnostic virology.
Materials and Methods
Specimens
Specimens submitted in virus transport medium (VTM)
for routine screening of HSV were randomly selected for
inclusion in this study on a prospective basis. There were
262 specimens tested by LC-PCR, rapid antigen EIA and
inoculation in A549 cell cultures. This included 106 cuta-
neous, 20 ocular, 106 anogenital, 1 respiratory and 29 site
unspecified specimens. Individual aliquots of each speci-
men were prepared for HSV DNA amplification by the
LightCycler (LC-PCR), rapid enzyme immunoassay of
HSV antigen and culture amplification followed by sub-
typing with enyzme immunoassay [7]. DNA was extracted
from 200 µl of each specimen using QIAamp DNA mini
kit according to the manufacturer's method (QIAGEN).
Extracted DNA was resuspended in 200 µl of elution buff-
er and 5 µl was used in the LC-PCR or PCR-ELISA test.
HSV-1 and 2
The SC16 strain of HSV-1 and MS strain of HSV-2 were
used as positive controls and titration determinations.
SC16 was a gift from Dr A. Simmons [14]. The MS strain
of HSV-2 was obtained from the ATCC (VR 540). These vi-
ruses were grown and passaged according to standard vi-
rological methods [12].
Routine detection of HSV by rapid antigen EIA and cell cul-
ture amplification
Specimens submitted for routine HSV screening were test-
ed in the rapid antigen EIA and inoculated in A549 cell
cultures. Inoculated cell cultures were subsequently tested
for HSV by enzyme immunoassay after four days post in-
oculation. This in-house developed test is called the cul-
ture amplified HSV test [7]. HSV subtype was
differentiated in the culture amplified test (but not in the
rapid antigen EIA) by comparing binding ratios of viral
isolates with specific monoclonal antibodies to HSV-1 or
2.
LightCycler PCR (LC-PCR)
The previously described [2] forward primer, HSV pol F
(5' GCTCGAGTGCGAAAAAACGTTC 3') and a new re-
verse primer, HSV pol A (5' TGCGGTTGATAAACGCG-
CAGT 3') [11] were used to amplify a 140 bp product. A
pair of newly designed fluorescence labelled probes, HSV-
2 FLU (5' GCGCACCAGATCCACGCCCTTGATGAGC-
FLUOR) and HSV-2 LCR (5' LC-Red 640-CTTGCCCCCG-
CAGATGACGCC-phos) were used for real-time detection
and melting temperature differentiation of HSV-1 and 2.
The LC-PCR master mix contained the following: 1×  Fast-
Start Taq DNA polymerase reaction buffer (Roche Molec-
ular Diagnostics) which included a dNTP mix (containing
dUTP instead of dTTP), 3 mM MgCl2, 0.5 µM of each
primer, 0.2 µM HSV-2 FLU and 0.4 µM HSV-2 LCR. Cy-
cling conditions were as follows: initial denaturation/BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/12
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FastStart Taq DNA polymerase activation at 95°C/10 min,
45 cycles of denaturation at 95°C/5 sec, annealing at
58°C/10 sec (with fluorescence acquisition at the end of
each annealing stage) and extension at 72°C/12 sec. After
amplification was complete, melting curve analysis was
performed as follows: denaturation at 95°C/20 sec, an-
nealing at 45°C/30 sec followed by a gradual increase in
temperature (transition rate of 0.1°C/sec) to 85°C with
continuous fluorescence acquisition.
Differentiation of HSV 1 and 2 by LightCycler melting 
curve analysis
The melting temperature of the HSV-2 LCR probe can be
used to determine whether the amplified DNA sequence
is related to HSV-1 or 2. The probe melting temperature is
that at which 50% has dissociated from the template
strand. If the first negative derivative (-dF/dT) of the melt-
ing curve is plotted, the melting temperature is calculated
as the turning point of that curve. The HSV-2 LCR probe
was designed to bind to a region where there was a 2 base
pair difference with HSV-1. The probe sequence is exactly
complementary to HSV-2 DNA. The probe has a melting
peak at ca. 58°C when hybridised to HSV-1 DNA and a
peak at ca. 71°C with a shoulder at ca. 66°C when hybrid-
ised to HSV-2 DNA.
Cloning HSV DNA
A 230 bp region of the pol gene which included the LC-
PCR target region was amplified from HSV-1 and 2 in sep-
arate reactions using primers HSV pol F1 (5'AGAT-
GGCGAGCCACATCTC 3') and HSV pol R1
(5'GGATACGGTATCGTCGTAAAAC 3'). The amplifica-
tion mixture contained the following: 10×  AmpliTaq Gold
PCR buffer containing 150 mM Tris-HCl and 500 mM
KCl, pH of 8.3 (PE Applied Biosystems), 200 µM of each
dNTP, 1.5 mM MgCl2, 1 µM each primer and 1 U Ampli-
Taq Gold. The PCR amplification consisted of one cycle of
95°C/5 min, followed by 30 cycles of 95°C/10 s, 55°C/15
s and 72°C/30 s. This was followed by an extension cycle
at 72°C/5 min and incubation at 4°C. The PCR product
was purifed from an agarose gel using the QIAquick Gel
Extraction Kit (QIAGEN) according to the manufacturer's
protocol. The amplicon was cloned directly into pGEM®-T
easy vector using the pGEM®-T Easy Vector System accord-
ing to the manufacturer's protocol (Promega). The identi-
ty of individual clones was confirmed by sequencing both
strands of the viral DNA insert. Plasmid DNA prepara-
tions were then made using QIAprep Spin Miniprep Kits
(QIAGEN) according to the manufacturer's instructions.
The plasmids were digested with PstI (Promega) (which
cuts at one site only in the recombinant plasmid) and the
linear form was purified from an agarose gel as described
earlier.
HSV PCR-ELISA
HSV DNA within a region (different from that amplified
in the LC-PCR) of the polymerase gene was amplified
with the following primer pair pol [L]5'-ATCAACTTC-
GACTGGCCCTTC-3' and pol [R]5'-CCGTACATGTCGAT-
GTTCACC-3' [10]. The amplified product was hybridized
with a biotin-labelled probe, bPolprb5'-CGCGTGT-
GGGACATXGGCCAGAGCCACTT-3'. The 'X' nucleotide
in this probe was substitued with inosine due to a single
base difference between HSV-1 and HSV-2 at that position
(GenBank accession numbers M12356 and M16321 re-
spectively). In the dNTP mix, 50 µM dTTP was replaced
with digoxygenin-labelled dUTP:dTTP in the ratio of 1:19.
The PCR amplification cycle consisted of an initial dena-
turation at 95°C/10 min followed by 5 cycles of 95°C/45
s, 64°C/45 s, 72°C/1 min; 15 cycles of 95°C/45 s, 64°C/45
s, 72°C/1 min 30 s; 5 cycles of 95°C/45 s, 64°C/45 s,
72°C/2 min; 10 cycles of 95°C/45 s, 64°C/45 s, 72°C/2
min 30 s followed by incubation at 4°C. The amplified
DNA was detected in a DIG-ELISA kit according to the
manufacturer's instructions (Roche Molecular Diagnos-
tics). In the DIG-ELISA, biotin-labelled probe was bound
to streptavidin-coated microwells. The probe was then hy-
bridised to the denatured (with 0.4 M NaOH) single
strand DNA. The latter hybrid was detected with peroxi-
dase-labelled specific antibody to digoxygenin. The en-
zyme reaction was then detected using ABTS as
chromogen. In our laboratory, detection of amplified
DNA with the DIG-ELISA showed a 10–100 fold increase
in sensitivity compared to gel electrophoresis (unpub-
lished data but see also [8]). The limit of detection of HSV-
1 plasmid DNA (gift of Dr S. Efstatiou, Cambridge Univer-
sity, England) with PCR-ELISA was 120 copies/reaction
(equivalent to 24 copies/µl) (unpublished data).
DNA sequence analysis
DNA sequencing reactions were performed using the
BigDye™ terminator system (PE Applied Biosystems) and
the results determined using an ABI PRISM® 3700 DNA
Analyser (PE Applied Biosystems) according to the manu-
facturer's instructions. Sequence data were compared to
HSV-1 and 2 sequences obtained from GenBank (acces-
sion numbers M12356 and M16321 respectively), using a
multiple alignment progam from the Australian National
Genomic Information Service  [www.angis.org.au] .
Double blind coded samples
In order to confirm the absence of cross contamination
between samples during DNA extractions, 24 genital and
cutaneous samples, previously shown to be negative for
HSV by culture and LC PCR, were combined and the vol-
ume made up to 24 ml with viral transport medium.
Twenty-four 1 ml-aliquots were then prepared. Two of
these samples were spiked with HSV-1 and three with
HSV-2 under code. DNA was then extracted from these 24BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/12
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samples in four batches of six samples to simulate routine
diagnostic conditions.
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